Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3898 | 1885 | 32.7 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
1311 | 2 | PROSTAGLANDIN D 2//CRTH2//MOL BEHAV BIOL | 8520 |
3898 | 1 | THROMBOXANE A2 RECEPTOR//THROMBOXANE A2//THROMBOXANE RECEPTOR | 1885 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THROMBOXANE A2 RECEPTOR | authKW | 670101 | 3% | 65% | 64 |
2 | THROMBOXANE A2 | authKW | 365246 | 7% | 16% | 138 |
3 | THROMBOXANE RECEPTOR | authKW | 333550 | 2% | 47% | 44 |
4 | THROMBOXANE RECEPTOR ANTAGONIST | authKW | 194345 | 1% | 50% | 24 |
5 | THROMBOXANE ANTAGONISTS | authKW | 173359 | 1% | 63% | 17 |
6 | THROMBOXANE SYNTHASE INHIBITOR | authKW | 161401 | 1% | 59% | 17 |
7 | THROMBOXANE A2 RECEPTOR ANTAGONIST | authKW | 154240 | 1% | 48% | 20 |
8 | S 1452 | authKW | 124591 | 1% | 77% | 10 |
9 | PICOTAMIDE | authKW | 124415 | 1% | 59% | 13 |
10 | THROMBOXANE SYNTHASE | authKW | 118978 | 1% | 28% | 26 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 8151 | 39% | 0% | 736 |
2 | Peripheral Vascular Diseases | 3017 | 12% | 0% | 232 |
3 | Chemistry, Medicinal | 2010 | 10% | 0% | 194 |
4 | Hematology | 1751 | 10% | 0% | 188 |
5 | Cardiac & Cardiovascular System | 760 | 9% | 0% | 171 |
6 | Biochemistry & Molecular Biology | 413 | 16% | 0% | 311 |
7 | Endocrinology & Metabolism | 388 | 7% | 0% | 127 |
8 | Cell Biology | 203 | 7% | 0% | 139 |
9 | Physiology | 154 | 4% | 0% | 78 |
10 | Allergy | 119 | 1% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INFLAMMAT PHARMACOL S | 36437 | 0% | 38% | 6 |
2 | EXPT HEMODYNAM HEMOLIEGE | 32395 | 0% | 100% | 2 |
3 | PHARMACOL 171 ASHLEY AVE | 29153 | 0% | 60% | 3 |
4 | NAT SYNTHET DRUG | 26989 | 0% | 33% | 5 |
5 | NAT SYNTH DRUG | 25911 | 0% | 40% | 4 |
6 | 124 SAGISU 5 CHOME | 21595 | 0% | 67% | 2 |
7 | KLINIKUM MANNHEIM CLIN CHEM | 21595 | 0% | 67% | 2 |
8 | POB 1005 | 21595 | 0% | 67% | 2 |
9 | HEMODYNAM HEMOLIEGE | 19930 | 0% | 31% | 4 |
10 | CELL MOLEC PHARMACOL EXPTL THER EUT | 18218 | 0% | 38% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 32646 | 2% | 5% | 40 |
2 | PROSTAGLANDINS | 13448 | 2% | 2% | 35 |
3 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 12226 | 2% | 2% | 37 |
4 | THROMBOSIS RESEARCH | 11609 | 5% | 1% | 86 |
5 | CARDIOVASCULAR DRUG REVIEWS | 8648 | 1% | 4% | 15 |
6 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 5321 | 4% | 0% | 84 |
7 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 4942 | 2% | 1% | 31 |
8 | EICOSANOIDS | 4768 | 0% | 5% | 6 |
9 | EUROPEAN JOURNAL OF PHARMACOLOGY | 4659 | 5% | 0% | 91 |
10 | BRITISH JOURNAL OF PHARMACOLOGY | 3537 | 3% | 0% | 63 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THROMBOXANE A2 RECEPTOR | 670101 | 3% | 65% | 64 | Search THROMBOXANE+A2+RECEPTOR | Search THROMBOXANE+A2+RECEPTOR |
2 | THROMBOXANE A2 | 365246 | 7% | 16% | 138 | Search THROMBOXANE+A2 | Search THROMBOXANE+A2 |
3 | THROMBOXANE RECEPTOR | 333550 | 2% | 47% | 44 | Search THROMBOXANE+RECEPTOR | Search THROMBOXANE+RECEPTOR |
4 | THROMBOXANE RECEPTOR ANTAGONIST | 194345 | 1% | 50% | 24 | Search THROMBOXANE+RECEPTOR+ANTAGONIST | Search THROMBOXANE+RECEPTOR+ANTAGONIST |
5 | THROMBOXANE ANTAGONISTS | 173359 | 1% | 63% | 17 | Search THROMBOXANE+ANTAGONISTS | Search THROMBOXANE+ANTAGONISTS |
6 | THROMBOXANE SYNTHASE INHIBITOR | 161401 | 1% | 59% | 17 | Search THROMBOXANE+SYNTHASE+INHIBITOR | Search THROMBOXANE+SYNTHASE+INHIBITOR |
7 | THROMBOXANE A2 RECEPTOR ANTAGONIST | 154240 | 1% | 48% | 20 | Search THROMBOXANE+A2+RECEPTOR+ANTAGONIST | Search THROMBOXANE+A2+RECEPTOR+ANTAGONIST |
8 | S 1452 | 124591 | 1% | 77% | 10 | Search S+1452 | Search S+1452 |
9 | PICOTAMIDE | 124415 | 1% | 59% | 13 | Search PICOTAMIDE | Search PICOTAMIDE |
10 | THROMBOXANE SYNTHASE | 118978 | 1% | 28% | 26 | Search THROMBOXANE+SYNTHASE | Search THROMBOXANE+SYNTHASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NAKAHATA, N , (2008) THROMBOXANE A(2): PHYSIOLOGY/PATHOPHYSIOLOGY, CELLULAR SIGNAL TRANSDUCTION AND PHARMACOLOGY.PHARMACOLOGY & THERAPEUTICS. VOL. 118. ISSUE 1. P. 18-35 | 128 | 66% | 164 |
2 | HALL, SE , (1991) THROMBOXANE A2 RECEPTOR ANTAGONISTS.MEDICINAL RESEARCH REVIEWS. VOL. 11. ISSUE 5. P. 503 -579 | 201 | 65% | 80 |
3 | DOGNE, JM , DE LEVAL, X , HANSON, J , FREDERICH, M , LAMBERMONT, B , GHUYSEN, A , CASINI, A , MASEREEL, B , RUAN, KH , PIROTTE, B , ET AL (2004) NEW DEVELOPMENTS ON THROMBOXANE AND PROSTACYCLIN MODULATORS - PART I: THROMBOXANE MODULATORS.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 10. P. 1223 -1241 | 132 | 57% | 50 |
4 | DOGNE, JM , HANSON, J , DE LEVAL, X , PRATICO, D , PACE-ASCIAK, CR , DRION, P , PIROTTE, B , RUAN, KH , (2006) FROM THE DESIGN TO THE CLINICAL APPLICATION OF THROMBOXANE MODULATORS.CURRENT PHARMACEUTICAL DESIGN. VOL. 12. ISSUE 8. P. 903 -923 | 113 | 47% | 36 |
5 | TING, HJ , MURAD, JP , ESPINOSA, EVP , KHASAWNEH, FT , (2012) THROMBOXANE A(2) RECEPTOR: BIOLOGY AND FUNCTION OF A PECULIAR RECEPTOR THAT REMAINS RESISTANT FOR THERAPEUTIC TARGETING.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS. VOL. 17. ISSUE 3. P. 248 -259 | 69 | 56% | 10 |
6 | HALUSHKA, PV , (2000) THROMBOXANE A(2) RECEPTORS: WHERE HAVE YOU GONE?.PROSTAGLANDINS & OTHER LIPID MEDIATORS. VOL. 60. ISSUE 4-6. P. 175 -189 | 72 | 70% | 35 |
7 | DOGNE, JM , HANSON, J , DE LEVAL, X , MASEREEL, B , KOLH, P , PIROTTE, B , (2004) NEW DEVELOPMENTS ON THROMBOXANE MODULATORS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 4. ISSUE 6. P. 649 -657 | 70 | 63% | 9 |
8 | HUANG, JS , RAMAMURTHY, SK , LIN, X , LE BRETON, GC , (2004) CELL SIGNALLING THROUGH THROMBOXANE A(2) RECEPTORS.CELLULAR SIGNALLING. VOL. 16. ISSUE 5. P. 521 -533 | 86 | 44% | 104 |
9 | DOGNE, JM , DE LEVAL, X , DELARGE, J , MASEREEL, B , (2001) RECENT DEVELOPMENTS OF THROMBOXANE MODULATORS.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 11. ISSUE 11. P. 1663 -1675 | 58 | 79% | 4 |
10 | DOGNE, JM , DE LEVAL, X , DELARGE, J , DAVID, JL , MASEREEL, B , (2000) NEW TRENDS IN THROMBOXANE AND PROSTACYCLIN MODULATORS.CURRENT MEDICINAL CHEMISTRY. VOL. 7. ISSUE 6. P. 609 -628 | 80 | 58% | 24 |
Classes with closest relation at Level 1 |